REYNO LEONARD
Chief Medical Officer
REYNO LEONARD has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company, with disclosures dating back to 2026. 3 of those filings fall inside the rolling window. Most recent filing: Jul 13, 2026.
On the most recent filing, REYNO LEONARD is listed as Chief Medical Officer at C4 Therapeutics, Inc. Inside the rolling window, REYNO LEONARD reported no open-market purchases and 1 open-market sale totaling $22K in CCCC.
Companies traded
Other insiders at CCCC
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$22K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has REYNO LEONARD made?
REYNO LEONARD has filed 3 SEC Form 4 filings (6 transaction rows) across 1 company since 2026.
Which companies does REYNO LEONARD trade?
REYNO LEONARD has filed SEC Form 4 disclosures for 1 company, including CCCC.
When was REYNO LEONARD's most recent SEC Form 4 filing?
REYNO LEONARD's most recent SEC Form 4 filing on Tracefour is dated Jul 13, 2026.
What is REYNO LEONARD's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, REYNO LEONARD is listed as Chief Medical Officer.
What is REYNO LEONARD's total buy and sell value in the current window?
Inside the rolling retention window, REYNO LEONARD bought $0 and sold $22K based on SEC Form 4 filings.
What was REYNO LEONARD's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 10,000 CCCC shares on 2026-01-16, worth $22K, per SEC Form 4 filings.